Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Inhibrx Biosciences, Inc
Inhibrx Biosciences, Inc
Eli Lilly and Company
Emory University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
Children's Oncology Group
National Institutes of Health Clinical Center (CC)